Aclasta 5mg injection

Product Description

Product Name : Aclasta 5mg injection

Product Form: injection

Pack size: 

Manufactured By : NOVARTIS PHARMA PAKISTAN LTD

Used For 

to treat osteoporosis (a disease that makes bones fragile) in women who have been through the menopause and in men.

Side Effect

• Abdominal or stomach pain.
• back pain.
• bad, unusual, or unpleasant (after) taste.
• bladder pain.
• blistering, crusting, irritation, itching, or reddening of the skin.
• bloody or cloudy urine.
• bone pain.
• burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings.
• Time Duration of Aclasta
• The recommended dose of zoledronic acid for treating osteoporosis is 5 mg (in 100 mL of solution) given intravenously once a year via a vented infusion line over at least 15 minutes. The duration of therapy is restricted to no more than 3 years.

Precautions

Patients must be appropriately hydrated prior to administration of Aclasta. This is especially important for the elderly (≥ 65 years) and for patients receiving diuretic therapy. Adequate calcium and vitamin D intake are recommended in association with Aclasta administration.